Exp Clin Endocrinol Diabetes 2011; 119(5): 265-270
DOI: 10.1055/s-0031-1271705
Article

© J. A. Barth Verlag in Georg Thieme Verlag KG Stuttgart · New York

Proteome Analysis of Differential Protein Expression in Brain of Rats with Type 1 Diabetes Mellitus

X. Li1 , W. Pan1 , G. Z. Yang1 , Y. N. Di1 , F. Zhao1 , L. Y. Zhu1 , Z. H. Jiang1
  • 1Department of Medical Laboratory, Guiyang Medical College, Department of Clinical Biochemistry, Affiliated Hospital of Guiyang Medical College, Guiyang, Guizhou, P.R. China
Further Information

Publication History

received 26.11.2010 first decision 15.01.2011

accepted 19.01.2011

Publication Date:
06 April 2011 (online)

Abstract

Aim of the study: Proteomic approach was applied to identify differential protein expressed in brain of rats with type 1 diabetes mellitus (T1DM) in order to search for potential biomarkers for pathological changes of brain with T1DM.

Methods: Proteins were extracted from brain tissues of T1DM rats and healthy control rats, separated by 2-DE and identified by MALDI-TOF-MS. The results were validated by Western blot analysis and immunohistochemistry (IHC).

Results: A total of 8 proteins from the 24 differentially expressed spots were identified by MALDI-TOF-MS. The proteins identified were vitamin D-dependent calcium-binding protein, creatine kinase B-type (B-CK), myosin light chain kinase (MLCK), HSP60 and HSP71, ATP synthase, cyclin-G, pantothenate kinase-1 (PANK1), respectively. 3 proteins were up-regulated and 5 proteins were down-regulated from the T1DM rats. Of the 8 proteins identified, MLCK was confirmed by Western blot and IHC.

Conclusion: This work demonstrates that a comprehensive strategy of proteomic identification should be a useful tool for understanding of diabetic encephalopathy mechanism. And the differential proteins such as MLCK may be give clues about the pathogenesis of diabetic encephalopathy.

References

  • 1 Bao Y, Jiang L, Shi YQ. et al . Increased expression of phosphorylated Smad2 and Smad3 in the hippocampus of streptozotocin-induced diabetic rats.  Exp Clin Endocrinol Diabetes. 2010;  118 (1) 47-50 [PubMed: 19834880]
  • 2 Brands AM, Kessels RP, de Haan EH. et al . Cerebral dysfunction in type 1 diabetes: effects of insulin, vascular risk factors and blood glucose levels.  Eur J Pharmacol. 2004;  490 (1–3) 159-168 [PubMed: 15094082]
  • 3 Fazeli SA. Neuroprotection in diabetic encephalopathy.  Neurodegenerative Dis. 2009;  6 (5–6) 213-218 [PubMed: 20145418]
  • 4 Fountoulakis M. Application of proteomics technologies in the investigation of the brain.  Mass Spectrum Rev. 2004;  23 (4) 231-258 [PubMed: 15133836]
  • 5 Fountoulakis M, Kossida S. Proteomics-driven progress in neurodegeneration research.  Electrophoresis. 2006;  27 (8) 1556-1573 [PubMed: 16555340]
  • 6 He RX, Gu CL, Shen F. et al . Changes in expression of adrenomedullin in the myocardium of streptozotocin-induced diabetic rats.  Chin Med J. 2007;  120 (3) 187-191 [PubMed: 17355819]
  • 7 Huber JD, VanGilder RL, Houser KA. Streptozotocin-induced diabetes progressively increases blood-brain barrier permeability in specific brain regions in rats.  Am J Physiol Heart Circ Physiol. 2006;  291 (6) 2660-2668 [PubMed: 16951046]
  • 8 Jian X, Szaro BG, Schmidt JT. Myosin light chain kinase: expression in neurons and up-regulation during axon regeneration.  J Neurobiol. 1996;  31 (3) 567-578 [PubMed: 8910795]
  • 9 Li ZG, Sima AA. C-peptide and central nervous system complications in diabetes.  Exp Diabesity Res. 2004;  5 (1) 9-90 [PubMed: 15198373]
  • 10 Liang XC, Guo SS, Hagino N. Current status of clinical and experimental researches on cognitive impairment in diabetes.  Chin J Integr Med. 2006;  12 (1) 68-74 [PubMed: 16571291]
  • 11 Messier C. Impact of impaired glucose tolerance and type 2 diabetes on cognitive ageing.  Neurobiol Aging. 2005;  26 (suppl 1) 26-30 [PubMed: 16236384]
  • 12 Mochida S, Kobayashi H, Matsuda Y. et al . Myosin II is involved in transmitter release at synapses formed between rat sympathetic neurons in culture.  Neuron. 1994;  13 (5) 1331-1142 [PubMed: 7946350]
  • 13 Pandey A, Mann M. Proteomics to study genes and genomes.  Nature. 2000;  405 (6788) 837-846 [PubMed: 10866210]
  • 14 Pasquier F, Boulogne A, Leys D. et al . Diabetes mellitus and dementia.  Diabetes Metab. 2006;  32 (5Pt1) 403-414 [PubMed: 17110895]
  • 15 Rabilloud T. Two-dimensional gel electrophoresis in proteomics: Old, old fashioned, but it still climbs up the mountains.  Proteomics. 2002;  2 (1) 3-10 [PubMed: 11788986]
  • 16 Ryan TA. Inhibitors of myosin light chain kinase block synaptic vesicle pool mobiliztion during action potential firing.  J Neurosci. 1999;  19 (4) 1317-1323 [PubMed: 9952409]
  • 17 Sasaki N, Fukatsu R, Tsuzuki K. et al . Advanced glycation end products in Alzheimer's disease and other neurodegenerative disease.  Am J Pathol. 1998;  153 (4) 149-1155 [PubMed: 9777946]
  • 18 Stasyk T, Morandell S, Bakry R. et al . Quantitative detection of phosphoproteins by combination of two-dimensional difference gel electrophoresis and phosphospecific fluorescent staining.  Electrophoresis. 2005;  26 (14) 2850-2854 [PubMed: 15966015]
  • 19 Shin DH, Chun YS, Lee KH. et al . Arrest defective-1 controls tumor cell behavior by acetylating myosin light chain kinase.  PLoS One. 2009;  14 (4) e7451 [PubMed: 19826488]
  • 20 Sun Y, Zang Z, Xu X. et al . Differential proteomics identification of HSP90 as potential serum biomarker in hepatocellular carcinoma by two-dimensional electrophoresis and mass spectrometry.  Int J Mol Sci. 2010;  11 (4) 1423-1433 [PubMed: 20480028]
  • 21 van den Berg E, Reijmer YD, de Bresser J. et al . A 4 year follow-up study of cognitive functioning in patients with type 2 diabetes mellitus.  Diabetologia. 2010;  53 (1) 58-65 [PubMed: 19882137]
  • 22 Wang T, Fu FH, Han B. et al . Aspirin attenuates cerebral ischemic injury in diabetic rats.  Exp Clin Endocrinol Diabetes. 2009;  117 (4) 181-185 [PubMed: 9053022]
  • 23 Wild S, Roglic G, Green A. et al . Global prevalence of diabetes: estimates for the year 2000 and projections for 2030.  Diabetes Care. 2004;  27 (5) 1047-1053 [PubMed: 15111519]
  • 24 Xu L, Li B, Cheng M. et al . Oral administration of grape seed proanthocyanidin extracts down-regulate RAGE dependant nuclear factor-kappa BP65 expression in the hippocampus of streptozotocin induced Diabetic rats.  Exp Clin Endocrinol diabetes. 2008;  116 (4) 215-224 [PubMed: 18273752]
  • 25 Yang W, Lu J, Weng J. et al . Prevalence of diabetes among men and women in China.  N Engl J Med. 2010;  362 (12) 1090-1101 [PubMed: 20335585]
  • 26 Zhang XG, Yan H, Shen YL. et al . Decreased thrombospondin-I (TSP-I) expression in the hippocampus of streptozotocin-induced diabetic rats.  Exp Clin Endocrinol Diabetes. 2008;  116 (6) 309-314 [PubMed: 18700275]

Correspondence

W. PanMD 

Department of Medical

Laboratory

Guiyang Medical College

550004 Guiyang

Phone: +86 0851 6780726

Fax: +86 0851 6761424

Email: pw_6602@sina.com